These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20307969)

  • 1. Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.
    Korpal M; Kang Y
    Eur J Cancer; 2010 May; 46(7):1232-40. PubMed ID: 20307969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamic roles of TGF-β in cancer.
    Meulmeester E; Ten Dijke P
    J Pathol; 2011 Jan; 223(2):205-18. PubMed ID: 20957627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1.
    Ganapathy A; Paterson IC; Prime SS; Eveson JW; Pring M; Price N; Threadgold SP; Davies M
    Cancer Lett; 2010 Dec; 298(1):107-18. PubMed ID: 20663607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of transforming growth factor beta impact in breast development and cancer.
    Serra R; Crowley MR
    Endocr Relat Cancer; 2005 Dec; 12(4):749-60. PubMed ID: 16322320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large- and small-molecule inhibitors of transforming growth factor-beta signaling.
    Akhurst RJ
    Curr Opin Investig Drugs; 2006 Jun; 7(6):513-21. PubMed ID: 16784021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of transforming growth factor beta in cancer.
    Pasche B
    J Cell Physiol; 2001 Feb; 186(2):153-68. PubMed ID: 11169452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of transforming growth factor beta antisense and interleukin-2 gene therapy in the murine ovarian teratoma model.
    Dorigo O; Shawler DL; Royston I; Sobol RE; Berek JS; Fakhrai H
    Gynecol Oncol; 1998 Nov; 71(2):204-10. PubMed ID: 9826461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta and cancer.
    Bierie B; Moses HL
    Cytokine Growth Factor Rev; 2006; 17(1-2):29-40. PubMed ID: 16289860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of TGF-beta signalling inhibitors for cancer therapy.
    Yingling JM; Blanchard KL; Sawyer JS
    Nat Rev Drug Discov; 2004 Dec; 3(12):1011-22. PubMed ID: 15573100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate.
    Danielpour D
    Eur J Cancer; 2005 Apr; 41(6):846-57. PubMed ID: 15808954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta and colorectal carcinogenesis.
    Roman C; Saha D; Beauchamp R
    Microsc Res Tech; 2001 Feb; 52(4):450-7. PubMed ID: 11170304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta.
    Borger DR; Mi Y; Geslani G; Zyzak LL; Batova A; Engin TS; Pirisi L; Creek KE
    Virology; 2000 May; 270(2):397-407. PubMed ID: 10792999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression.
    Maluccio M; Sharma V; Lagman M; Vyas S; Yang H; Li B; Suthanthiran M
    Transplantation; 2003 Aug; 76(3):597-602. PubMed ID: 12923450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.